Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 1;76(3):411-419.
doi: 10.22092/ARI.2020.342861.1487. eCollection 2021 Summer.

Comparison of Two Different Methods for the Extraction of Outer Membrane Vesicles from the Bordetella pertussis as a Vaccine Candidate

Affiliations

Comparison of Two Different Methods for the Extraction of Outer Membrane Vesicles from the Bordetella pertussis as a Vaccine Candidate

M S Soltani et al. Arch Razi Inst. .

Abstract

Despite the availability of a vaccine, pertussis is still a worldwide health problem. Outer membrane vesicles (OMVs) in gram-negative bacteria can stimulate the immune system due to several outer membrane proteins and are very good candidates in vaccine development. OMVs obtained from Bordetella pertussis contain several antigens, which are considered immunogenic, and could make them a potential candidate for vaccine production. The current study aimed to compare the current OMV extraction method (with ultracentrifuge) and a modified extraction method (without ultracentrifuge) and to evaluate the physicochemical properties as well as the expression of their main virulence factors. Vaccinal strain BP134 grown on Bordet Gengo agar were inoculated in Modified Stainer-Scholte medium for mass cultivation. OMVs were prepared using two different methods. They were then stained and examined with a transmission electron microscope. Protein contents were measured by the Bradford method, and then the protein profile was evaluated by SDS-PAGE. The presence of immunogenic antigens was detected by Western blotting. The size and shape of the OMVs obtained from the modified method without the use of ultracentrifuge were similar to the current method and had a size between 40 and 200 nm. The total protein yields of the OMV isolated using the current and modified methods were 800 and 600 µg/ml, respectively. Evaluating the protein profile of extracted OMVs showed the presence of different proteins. Finally, the presence of PTX, PRN, and FHA was observed in OMVs extracted from both methods. Comparison of the two OMV extraction methods showed that the obtained vesicles have a suitable and similar shape and size as well as the expression of three important pathogenic factors as immunogens. Despite the relatively low reduction in protein yield as the modified method does not require ultracentrifuge, this extraction method can be used as a suitable alternative for extracting the outer membrane vesicles from B. pertussis, especially in developing countries. It should be noted that further experiments including immunogenicity determination of OMVs obtained as vaccine candidates in animal models are required.

Keywords: outer membrane vesicle; virulence factors; B. pertussis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Negatively stained Bordetella pertussis OMVs examined with an electron microscope. (A) shows the OMV obtained from B. pertussis with the current method. (B) shows the OMV obtained from B. pertussis with the modified method. Vesicle sizes range from 40 to 200 nm.
Figure 2
Figure 2
SDS-PAGE Pattern of OMV containing PTXS1, Prn, FHA. Lane 1 shows the OMV obtained from B. pertussis using the modified method, and lane 2 shows the OMV obtained with the current protocol. M: Marker. Molecular weights are indicated at the right.
Figure 3
Figure 3
Western blot of OMVs using anti-PTX S1, anti-PRN, and anti-FHA. Lane 1 shows the OMV obtained from B. pertussis with the modified method, and lane 2 shows the OMV obtained from the current protocol. Molecular weights are indicated at the right.

References

    1. Howard C. Bordetella pertussis: Epidemiology, Virulence Factors, Pathogenesis, Treatments, and Vaccines. 2016
    1. Mooi FR. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol. 2010;10(1):36–49. - PubMed
    1. Breakwell L, Kelso P, Finley C, Schoenfeld S, Goode B, Misegades LK, et al. Pertussis Vaccine Effectiveness in the Setting of Pertactin-Deficient Pertussis. Pediatrics. 2016:e20153973. - PubMed
    1. Zaretzky FR, Gray MC, Hewlett EL. Mechanism of association of adenylate cyclase toxin with the surface of Bordetella pertussis: a role for toxin–filamentous haemagglutinin interaction. Mol Microbiol. 2002;45(6):1589–98. - PubMed
    1. Bolotin S, Harvill ET, Crowcroft NS. What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine. Pathog Dis. 2015;73(8) - PMC - PubMed

Publication types

Substances